How is intertrigo treated?

Treatment controls moisture and friction first, then targets any infection with an antifungal or antibiotic, as the treatment section above explains.

Intertrigo: Causes & Treatment

Understand what your skin conditions results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

What intertrigo actually is and where it starts

Intertrigo is an inflammatory skin condition that develops in areas where skin rubs against skin. The name comes from the Latin "inter" (between) and "terere" (to rub). It shows up in body folds: under the breasts, in the groin, between the buttocks, in the armpits, under abdominal folds, and between the toes. The initial trigger is mechanical. Skin-on-skin friction damages the outermost layer of the epidermis, the stratum corneum, which normally acts as a protective barrier.

When that barrier breaks down, moisture gets trapped. Sweat can't evaporate. The warm, damp environment becomes a breeding ground for bacteria and fungi that normally live on the skin in small numbers. The inflammation you see (redness, swelling, sometimes oozing or crusting) is your immune system responding to that breakdown. But intertrigo isn't an infection at the start. It's a reaction to physical irritation.

Bacterial or fungal?

Once the skin barrier is compromised, secondary infection is common. Candida albicans, a yeast, is the most frequent culprit. Bacterial overgrowth, particularly Staphylococcus aureus or Streptococcus species, can also take hold. When that happens, the rash may spread beyond the original fold. Candida usually brings a distinct odor and satellite pustules at the rash edges. Bacterial infection tends to cause more pronounced inflammation and discharge.

Is intertrigo contagious?

You can't catch it from someone else, and you can't spread the inflammatory rash to another person. The condition is caused by local factors: friction, moisture, and heat in your own skin folds. However, if intertrigo becomes secondarily infected with bacteria or fungi, those microorganisms can be transmitted through direct skin-to-skin contact or indirectly through shared towels or clothing. The infection, not the intertrigo, is what spreads. Understanding whether intertrigo is contagious helps clarify why proper hygiene and avoiding shared personal items matter when secondary infections develop.

How intertrigo connects to immune function, metabolic health, and the skin microbiome

Skin is an immune organ. When the barrier is intact, it keeps pathogens out and maintains a balanced population of resident microbes. Intertrigo disrupts that balance. The damaged skin allows bacteria and yeast to proliferate unchecked. But why some people develop persistent or recurrent intertrigo while others don't comes down to systemic factors.

Metabolic health plays a significant role. People with diabetes mellitus type 2 or prediabetes are at higher risk. Elevated blood glucose creates a more favorable environment for Candida growth. High glucose levels in sweat and interstitial fluid feed yeast, making secondary fungal infections more likely and harder to clear. Insulin resistance also impairs immune cell function, particularly neutrophils, which are responsible for clearing bacterial and fungal invaders.

Immune dysregulation matters. Chronic low-grade inflammation, reflected in markers like high-sensitivity C-reactive protein (hs-CRP), can make the skin more reactive to irritation. People with compromised immune systems (whether from medication, chronic illness, or aging) are more susceptible to both the initial breakdown and the secondary infections that follow.

The skin microbiome shifts in intertrigo. Normally, a diverse population of bacteria and fungi keeps any single species from dominating. In the warm, moist environment of a skin fold, that diversity collapses. Candida and Staphylococcus species outcompete beneficial microbes. This isn't just a local problem. Gut health influences skin health through the gut-skin axis. Dysbiosis in the gut, often driven by antibiotic use, poor diet, or chronic stress, can alter systemic immune tone and make the skin more prone to inflammatory flares.

What triggers intertrigo flares and why the same thing doesn't affect everyone

Intertrigo is triggered by a combination of mechanical, environmental, and physiological inputs. The most direct driver is friction. Skin rubbing against skin, especially in areas where movement is constant, wears down the protective barrier. Add moisture (from sweat, urine, or wound drainage), and the skin becomes macerated. Maceration softens the tissue, making it more vulnerable to further damage and microbial invasion.

Heat amplifies the problem. High ambient temperature or fever increases sweating. Tight clothing or occlusive fabrics trap moisture against the skin. Obesity increases the number and depth of skin folds, creating more surface area where friction and moisture can accumulate. Weight gain doesn't just add folds; it changes the biomechanics of how skin moves, increasing shear forces in areas like the groin and under the breasts.

Several additional factors contribute to flare risk:

Incontinence (urinary or fecal) provides constant moisture and chemical irritation that breaks down the skin barrier.
Limited mobility prevents repositioning to relieve pressure and friction, particularly in bedridden individuals.
Pregnancy increases skin fold depth and sweating due to hormonal changes and weight gain.
Menopause reduces estrogen, which thins the skin and impairs barrier function.
Corticosteroids (topical or systemic) thin the skin and suppress local immune defenses.
Antibiotics disrupt the skin and gut microbiome, allowing opportunistic organisms like Candida to flourish.
Immunosuppressants used for autoimmune conditions or after organ transplant increase susceptibility to both initial breakdown and secondary infections.

Why the same condition looks different and responds differently in different people

Two people with intertrigo in the same location can have completely different experiences. One clears with basic hygiene and a barrier cream. The other develops a persistent, recurrent rash that requires antifungal therapy and systemic intervention. The difference isn't random.

Genetics influence skin barrier function. Variants in genes that encode filaggrin, a protein critical for maintaining the stratum corneum, make the skin more permeable and prone to irritation. People with these variants are more likely to develop inflammatory skin conditions, including intertrigo, and less likely to respond to simple topical treatments.

Skin microbiome composition varies widely between individuals. Some people naturally harbor more Candida or Staphylococcus on their skin. Others have a more diverse microbial population that resists overgrowth. Prior antibiotic use, hygiene practices, and even diet shape the skin microbiome in ways that influence how quickly intertrigo progresses from inflammation to infection.

Immune phenotype matters. Some people mount a strong inflammatory response to minor irritation, leading to more redness, swelling, and discomfort. Others have a blunted response, which may seem better initially but allows infection to take hold without obvious warning signs. Chronic stress, poor sleep, and nutritional deficiencies all modulate immune tone and affect how the body responds to skin barrier breakdown.

Metabolic baseline plays a role. Someone with well-controlled blood sugar and normal insulin levels will clear a Candida infection faster than someone with insulin resistance or elevated hemoglobin A1c (HbA1c). Chronic inflammation, reflected in markers like hs-CRP, makes the skin more reactive and slower to heal.

Intertrigo treatment: creams and care

Treatment starts with moisture and friction control. Keep the fold clean, dry, and cool, and pat it dry rather than rubbing. Absorptive powders and barrier creams reduce moisture and friction, and light, loose, absorbent clothing helps.

The best cream depends on the cause:

Uninfected rash — A barrier cream with zinc oxide or petrolatum reduces friction.
Candida infection — A topical antifungal such as clotrimazole or miconazole clears the yeast.
Bacterial infection — Topical or oral antibiotics are chosen based on the organism.

If the rash keeps coming back, addressing obesity, diabetes, or incontinence matters more than any cream.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

When skin symptoms point to something systemic

Persistent or recurrent intertrigo, especially when it doesn't respond to standard treatment, can signal metabolic or immune dysfunction that topical treatments don't address. Bloodwork can surface the drivers:

Blood sugar — Recurrent Candida infections are common in undiagnosed or poorly controlled diabetes. Fasting glucose, HbA1c, and insulin reveal insulin resistance or prediabetes. The triglyceride-glucose index (TyG index) combines triglycerides and glucose into one measure of insulin sensitivity.
Inflammation — hs-CRP and erythrocyte sedimentation rate (ESR) reflect systemic inflammation from obesity, metabolic syndrome, or autoimmune conditions, which slows skin repair.
Immune cells — A complete blood count with differential shows whether low lymphocytes or elevated neutrophils point to immune dysregulation.
Nutrients — Low vitamin D, zinc, or vitamin B12 slows skin repair and raises infection risk, especially with restricted diets, malabsorption, or chronic illness.
Gut — A gut microbiome analysis reveals dysbiosis, such as Candida overgrowth or loss of beneficial bacteria like Faecalibacterium prausnitzii or Akkermansia muciniphila.

People on long-term corticosteroids, chemotherapy, or immunosuppressants should be monitored more closely for signs of infection when intertrigo develops. When you understand what's driving the breakdown, your next step is based on data, not guesswork.

Frequently Asked Questions

Intertrigo itself is not contagious — the inflammatory rash cannot be transmitted from person to person. It is caused by local factors: friction, moisture, and heat in your own skin folds. However, if secondary infection develops with bacteria or fungi like Candida, those microorganisms can be transmitted through direct skin-to-skin contact or indirectly through shared towels or clothing. The infection, not the intertrigo itself, is what can spread.

Skin-on-skin friction damages the stratum corneum, allowing moisture from sweat to become trapped in the fold. The warm, damp environment promotes overgrowth of bacteria and fungi normally present on the skin in small numbers. Candida albicans is the most frequent secondary infector. Obesity increases the number and depth of skin folds. Incontinence, limited mobility, occlusive clothing, and immunosuppressive medications all increase the risk of both barrier breakdown and secondary infection.

Recurrence is typically driven by unresolved underlying factors. Insulin resistance or poorly controlled diabetes creates elevated glucose in sweat and interstitial fluid that continuously feeds Candida overgrowth. Chronic inflammation from metabolic syndrome makes skin more reactive and slower to heal. Obesity maintains the structural conditions — deep folds, persistent moisture — that trigger breakdown. Gut dysbiosis and antibiotic use disrupt the skin microbiome, allowing opportunistic organisms to proliferate repeatedly.

Intertrigo is the inflammatory skin fold rash itself — initially caused by friction and moisture with no infection involved. A yeast infection (candidal intertrigo) is the secondary complication that develops when Candida overgrows in the compromised, moisture-rich environment. A yeast infection in skin folds presents with satellite pustules beyond the main rash border and a characteristic odor. Antifungal treatment targets the Candida, but the underlying intertrigo requires addressing moisture, friction, and metabolic drivers.

Diabetes mellitus and insulin resistance are the most common systemic links — elevated blood glucose feeds Candida directly and impairs neutrophil function that clears infection. Obesity increases skin fold depth and shear forces. Metabolic syndrome creates chronic low-grade inflammation that slows skin repair. Immune suppression from corticosteroids, chemotherapy, or autoimmune disease medications increases susceptibility to secondary infections. Nutritional deficiencies in vitamin D, zinc, and B12 impair wound healing and immune response.

Fasting glucose, HbA1c, and insulin reveal insulin resistance or undiagnosed diabetes driving recurrent Candida infections. The triglyceride-glucose index integrates triglycerides and glucose into a single insulin sensitivity metric. hs-CRP and ESR reflect systemic inflammation affecting skin integrity. A complete blood count with differential assesses immune cell populations for dysregulation. Vitamin D, zinc, and vitamin B12 identify nutritional deficiencies impairing healing. A gut microbiome analysis can reveal Candida overgrowth and dysbiosis contributing to skin symptoms.